Cite
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
MLA
Houser, Katherine V., et al. “DNA Vaccine Priming for Seasonal Influenza Vaccine in Children and Adolescents 6 to 17 Years of Age: A Phase 1 Randomized Clinical Trial.” PLoS ONE, vol. 13, no. 11, Nov. 2018, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0206837.
APA
Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., Ledgerwood, J. E., & null, null. (2018). DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. PLoS ONE, 13(11), 1–18. https://doi.org/10.1371/journal.pone.0206837
Chicago
Houser, Katherine V., Galina V. Yamshchikov, Abbie R. Bellamy, Jeanine May, Mary E. Enama, Uzma Sarwar, Brenda Larkin, et al. 2018. “DNA Vaccine Priming for Seasonal Influenza Vaccine in Children and Adolescents 6 to 17 Years of Age: A Phase 1 Randomized Clinical Trial.” PLoS ONE 13 (11): 1–18. doi:10.1371/journal.pone.0206837.